# Zoe R Maylin Source: https://hello.cv/zoemaylin ## Work ### University of British Columbia ### Research Associate | Axitan Ltd ## Education ### University of Surrey | PhD ## Publications ### PROX1 is an early driver of lineage plasticity in prostate cancer Journal of Clinical Investigation journal-article ### Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer Cells journal-article ### Therapeutic Exploitation of Neuroendocrine Transdifferentiation Drivers in Prostate Cancer Cells journal-article ### A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer Frontiers in Oncology journal-article ### A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer Frontiers in Oncology journal-article ### A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer Frontiers in Oncology journal-article ### Front Cover: Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance (ChemMedChem 2/2023) ChemMedChem journal-article ### Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance ChemMedChem journal-article ### Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resistance ChemMedChem journal-article ### Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resistance ChemMedChem journal-article ### Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease Translational Oncology journal-article ### Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease Translational Oncology journal-article ### Breaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease Translational Oncology journal-article ## Source Read this profile on Hello.cv: https://hello.cv/zoemaylin Create your free profile at https://hello.cv